Publications
- Efficacy of weekly transtuzumab and paclitaxel in the treatment of women with HER-2/neu overexpressing metastatic breast cancer. The impact of taxane free interval on treatment outcomes2002 | First Faculty of Medicine
- Metastatic treatment of breast cancer in the light of new possibilities for chemotherapy, hormonal therapy and biotherapyPublication without faculty affiliation
- Fulvestrant in postmenopausal women with metastatic breast cancer progressing on prior endocrine therapy updated results from an expanded access programmePublication without faculty affiliation
- Weekly trastuzumab (T) and paclitaxel (P) in metastatic breast cancer (MBC). The impact of taxane free interval (TFI) on treatment outcomePublication without faculty affiliation
- Fulvestrant in postmenopausal women with metastatic breast cancer progressing on prior endocrine therapy - results from a compassionate use programPublication without faculty affiliation
- Uptake and Effectiveness of Risk-Reducing Surgeries in Unaffected Female BRCA1 and BRCA2 Carriers: A Single Institution Experience in the Czech Republic2023 | First Faculty of Medicine
- Preservation of fertility in young patients with breast cancer, including BRCA1, BRCA2 mutation carriers2023 | First Faculty of Medicine
- Trastuzumab deruxtecan in the treatment of patients with metastatic HER2‑low breast cancer2023 | First Faculty of Medicine
- Ultrasound appearance and targeted therapy of symptomatic neural lesions in the breast and chest wall after breast cancer surgery2023 | First Faculty of Medicine
- Bilateral Prophylactic Nipple-Sparing Mastectomy: Analysis of the Risk-Reducing Effect in BRCA1/2 Mutation Carriers2022 | First Faculty of Medicine
Loading network view...